TUCSON, Ariz. – University of Arizona startup GenetiRate has been acquired by biotechnology company IMV Technologies.Continue reading
Category Archives: AZBio News
AZBio Elects 2020 Officers and Welcomes New Board Members
The Arizona Bioindustry Association, Inc. (AZBio) Board of Directors has elected its 2021 officers and welcomes seven new board members in 2021. Continue reading
eNAMPT, the Inflammation-Regulatory Protein Specifically Targeted by Aqualung Therapeutic’s Monoclonal Antibody ALT-100, is now Tightly Linked to Outcomes in COVID-19 Infected Patients
TUCSON, AZ / ACCESSWIRE / February 11, 2021 / Several recent publications have now highlighted the involvement of extracellular nicotinamide phosphoribosyltransferase (eNAMPT) in the pathobiology of SARS-CoV-2 infection.
MILESTONE: Arizona Hits One Million Doses
PHOENIX — Governor Doug Ducey is applauding the hard work of Arizona’s medical professionals, volunteers and frontline workers as the state reaches one million vaccine doses administered today.
“We’ve reached a major milestone with our one millionth dose,” said Governor Ducey. “The dedication and hard work of many made this accomplishment possible. Nurses, doctors, health technicians, support staff, volunteers — to each and every one of you, thank you. ”
Botanisol Analytics and Ocean Insight Introduce First Laser Virus Screener
Free Resource for Businesses – Pandemic Response, Recovery and Planning
This handbook for businesses on pandemic response lessons learned with some considerations businesses can look at on re-opening, vaccine hesitancy, preparing for the next pandemic now, etc. was developed by the Northeast Business Group on Health. Continue reading
Coronavirus (COVID-19) Update: FDA Authorizes Monoclonal Antibody for Treatment of COVID-19
Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the investigational monoclonal antibody therapy bamlanivimab for the treatment of mild-to-moderate COVID-19 in adult and pediatric patients. Bamlanivimab is authorized for patients with positive results of direct SARS-CoV-2 viral testing who are 12 years of age and older weighing at least 40 kilograms (about 88 pounds), and who are at high risk for progressing to severe COVID-19 and/or hospitalization. This includes those who are 65 years of age or older, or who have certain chronic medical conditions.Continue reading
Final Steel Beam Tops Off The Refinery Building at the UA Tech Park at The Bridges
TUCSON, Ariz.– The steel frame and concrete floors are coming to completion at The Refinery. The final beam of The Refinery was placed, topping off the steel framework for the 120,000 square foot structure. The Refinery is the kickoff building to the new UA Tech Park at The Bridges, an extension campus birthed from the success of the UA Tech Park near Interstate 10 and Rita Road. Continue reading
Are COVID-19 Vaccines Safe and Effective?
COVID-19 Vaccines are viewed as the light at the end of the tunnel. We are not there yet but we will get there. Hundreds of millions of people in the United States and billions of people globally will need to be immunized against COVID-19. But, are these vaccines safe and effective? Would you recommend that someone you love get one?
C-Path Appoints Co-Directors to CURE Drug Repurposing Collaboratory Advisory Committee
TUCSON, Ariz., February 4, 2021 — Critical Path Institute (C-Path) today has announced the appointments of David Fajgenbaum, M.D., M.S., M.B.A., and Marco Schito, Ph.D., as co-directors of the advisory committee for C-Path’s CURE Drug Repurposing Collaboratory (CDRC) program.Continue reading